Xiaolin Nan

Xiaolin Nan received his B.S. and M.S. in Chemistry from Peking University, Beijing, and a Ph.D. in Biophysics from Harvard University, Cambridge. Xiaolin’s graduate studies focused on wet-chemistry approaches to fabricating aligned single wall carbon nanotubes and the biophysical analysis of dynamic processes in living cells using high time resolution, spatial precision and chemical selectivity strategies.

As a postdoctoral fellow with Dr. Steven Chu at the University of California, Berkeley, Dr. Joe Gray at the Lawrence Berkeley National Laboratory and Dr. Frank McCormick at the University of California at San Francisco, Xiaolin established a unique biological system for controlled expression of tagged proteins for single-molecule counting and localization using super resolution imaging based on PALM and STORM principles. Xiaolin investigated the oncogenic processes and intracellular trafficking of Ras-GTP dimer formation and Raf activation.

Xiaolin comes to Portland with his wife Ting Zheng, and his 8 month old son, Gavin.

Summer Gibbs

Summer Gibbs received her B.S. summa cum laude in Biochemistry from Whitworth College, Spokane, WA, and a Ph.D. in Biomedical Engineering from Dartmouth College, Hanover, NH. Summer’s graduate studies focused on noninvasive fluorescence technologies and tissue light transport for brain cancer detection and cancer therapy monitoring.

As a postdoctoral fellow with Dr. John Frangioni at the Harvard Medical School, Boston, MA, Summer developed near-infrared nerve-specific fluorescent contrast agents, derivatized and screed the fluorescent compounds ex vivo and in vivo for nerve specificity and performance for use in image-guided surgery.

Kimberly Beatty

Kimberly Beatty completed postdoctoral training at UC Berkeley in 2012, under advisor Dr. Carolyn Bertozzi, professor of chemistry.

Dr. Beatty’s research focuses on Mycobacterium tuberculosis, a bacterial pathogen that causes tuberculosis (TB). Decades of basic biological and medical research have sought to understand this devastating human disease. Yet there is still isn’t a good understanding of how M. tuberculosis is able to interact successfully with the proteins, organelles, cells and tissues that make up the human body. The Beatty Research Group will use approaches from the physical sciences to push the boundaries of what is known about TB. Overall, Dr. Beatty’s group will develop new chemical tools and molecular imaging approaches that will advance knowledge of mycobacterial biomarkers, infections and pathogenesis.